Yarrow Bioscience, Inc.

YARW

$37.70

Today

as of Aug 5, 16:56 ET

Last 30 days +16.36% Jun 29 → Aug 05

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$94M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 1 item

Jul 27 · 11:00 PR Business Wire

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease

Overview

52-week range

—

Avg surprise (last 1)

+43.5%

Avg reaction (last 0)

—

Earnings trends

EPS — actual vs estimate Actual Estimate

Earnings history

Date	Period	Actual EPS	Est	Surprise	YoY %Δ	Day react	Source
Thu Aug 14, 2025	Jun/2025	$-0.13	$-0.23	+43.5%	—	—	earnings

Upcoming

Date	Fiscal	Time	EPS Est	LY EPS	YoY %Δ
Thu Aug 13, 2026	Jun/2026	OTHER	—	-$6.50

Implied volatility — last 90 days

No IV snapshots yet for YARW.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗